Solid Lipid Nanoparticle for the Delivery of Docetaxel: A Review
Solid lipid nanoparticles are the forefront of the rapidly developing field of nanotechnology with several potential applications in drug delivery, clinical medicine and research. Due to its solid state it has greater stability than other nanocarrier systems. There are several other advantages like sustained release, improves bioavaibility and delivery of poorly water soluble drugs, helps in control of several pharmacokinetic parameters of drugs due to which use of SLN is increasing day by day. Various techniques can be used for the formulation of SLN i.e. solvent evaporation, microemulsification technique, high pressure homogenization and supercritical fluid method. It has several applications likes it is use in gene transfer therapy, also use in different drug delivery systmer like oral and pulmonary drug delivery system. Due to several advantages SLNs are widely used in chemotherapy for the treatment of the cancer. The use of SLN for the delivery of Docetaxel to tumor site have several benefits likes site specific delivery, less toxic effect, more cell cytotoxicity and more bioavaibility which leads to decrease in the dosing frequency. Docetaxel is an anticancer agent extracted from plant Taxus Baccata which is widely used in chemotherapy to treat cancer. This article contains the detail information of about the advantages, disadvantages, different method of preparation and several SLN loaded with Docetaxel.
Keywords: Solid lipid nanoparticles, drug delivery, clinical medicine, poorly water soluble drugs
2. Lingayat VJ, Zarekar NS, Shendge RS. Solid lipid nanoparticles: a review. Nanoscience and Nanotechnology Research. 2017 Apr; 2:67-72.
3. Li J, Yin T, Wang L, Yin L, Zhou J, Huo M. Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel. International journal of pharmaceutics. 2015 Apr 10; 483(1-2):38-48.
4. Tripathi K D. 2014. Pharmacological Classification of Drugs: With Dose and Preparation. 5th edition, Jaypee Brothers Medical Publishers Ltd. New Delhi.
5. Cancer.gov United of American: National Institue of Health; [Accesses December 25, 2016]. [updated 2016]. Available from: https://www.cancer.gov/types/breast/patient/breast- treatment-pdq.
6. Routh S, Nandagopal K. Patent survey of resveratrol, taxol, podophyllotoxin, withanolides and their derivatives used in anticancer therapy. Recent patents on biotechnology. 2017 Aug 1; 11(2):85-100.
7. Zhang X, Liang N, Gong X, Kawashima Y, Cui F, Sun S. Tumor-targeting micelles based on folic acid and α-tocopherol succinate conjugated hyaluronic acid for paclitaxel delivery. Colloids and Surfaces B: Biointerfaces. 2019 May 1; 177:11-8.
8. Han S, Sun R, Su H, Lv J, Xu H, Zhang D, Fu Y. Delivery of docetaxel using pH-sensitive liposomes based on D-α-tocopheryl poly (2-ethyl-2-oxazoline) succinate: Comparison with PEGylated liposomes. Asian Journal of Pharmaceutical Sciences. 2019 Jul 1; 14(4):391-404.
9. Jiang S, Mou Y, He H, Yang D, Qin L, Zhang F, Zhang P. Preparation and evaluation of self-assembly Soluplus®-sodium cholate-phospholipid ternary mixed micelles of docetaxel. Drug development and industrial pharmacy. 2019 Nov 2; 45(11):1788-98.
10. Verma P, Meher JG, Asthana S, Pawar VK, Chaurasia M, Chourasia MK. Perspectives of nanoemulsion assisted oral delivery of docetaxel for improved chemotherapy of cancer. Drug delivery. 2016 Feb 12; 23(2):479-88.
11. Ley J, Wildes TM, Daly K, Oppelt P, Adkins D. Clinical benefit of nanoparticle albumin-bound-paclitaxel in recurrent/ metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxel. Medical Oncology. 2017 Feb 1; 34(2):28.
12. Baek JS, Shin SC, Cho CW. Effect of lipid on physicochemical properties of solid lipid nanoparticle of paclitaxel. Journal of Pharmaceutical Investigation. 2012 Oct 1; 42(5):279-83.
13. Shagufta khan, Solid lipid nanoparticles a review World Journal of Pharmacy and Pharmaceutical Sciences, volume 1, may 2012, 96-115.
14. Ekambaram, Abdul Hasan Sathali A and Priyanka K , solid lipid nanoparticles and lipid nanostructures overview, scientific Review &Chemical communication, 2011; 2:216-220
15. Rawat, Jain MK, Singh A, Studies on binary lipid matrix based solid lipidnanoparticles of repaglinide, In vitro and in vivo evaluation, Journal of Pharmaceutical Sciences, 2011; 2:66-78.
16. Ramteke, K., Joshi, S. and Dhole, S., “Solid Lipid Nanoparticle: A Review”, IOSR Journal of Pharmacy, 2012; 2(6):34-44.
17. Yuan Q, Han J, Cong W, Ge Y, Ma D, Dai Z, Li Y, Bi X. Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity. International journal of nanomedicine. 2014; 9:4829.
18. Mosallaei N, Jaafari MR, Hanafi-Bojd MY, Golmohammadzadeh S, Malaekeh-Nikouei B. Docetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro, and in vivo evaluations. Journal of pharmaceutical sciences. 2013 Jun 1; 102(6):1994-2004.
19. Naguib YW, Rodriguez BL, Li X, Hursting SD, Williams III RO, Cui Z. Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation. Molecular pharmaceutics. 2014 Apr 7; 11(4):1239-49.
20. Cho HJ, Park JW, Yoon IS, Kim DD. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. International journal of nanomedicine. 2014; 9:495.
21. Pandey R, Sharma S, GKhuller GK. Oral SLN Based antitubercular chemotherapy, Tuberculosis (Edinb) 2005; 85:415-420.
22. Cavalli, R., Gasco, M.R., Chetoni, P., Burgalassi, S., Saettone, M.F. Solid lipid nanoparticles (SLN) as ocular delivery systems for tobramycin. Int J Pharm 2002; 238: 241-5.
23. Rudolph C, Schillinger U, Ortiz A, Tabatt K, Plank C, Muller RH, Application of novel Solid lipid nanoparticles (SLN) - gene vector formulations based on a diametric HIV-1 VAT - peptide in vitro and in vivo.Pharmaceutic Res, 2004; 21:1662-1669.
24. Wissing SA, Muller RH, Solid lipid nanoparticles (SLN) a novel carrier for U V blockers. Pharmazie 56, 2001, 783-786.
25. Xu Z, Chen L, Gu W, Gao Y, Lin L, Zhang Z, Xi Y, Li Y. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials. 2009 Jan 1; 30(2):226-32.
26. Zhang P, Chen L, Zhang Z, Lin L, Li Y. Pharmacokinetics in rats and efficacy in murine ovarian cancer model for solid lipid nanoparticles loading docetaxel. Journal of nanoscience and nanotechnology. 2010 Nov 1; 10(11):7541-4.
27. Pathak A, Tanmay M, Murthy RS. Development and characterization of docetaxel loaded anti-FGFR-1 modified solid lipid nanoparticles for breast cancer targeting. Int J Adv Pharm Biol Chem. 2012; 1:381-7.
28. Venishetty VK, Komuravelli R, Kuncha M, Sistla R, Diwan PV. Increased brain uptake of docetaxel and ketoconazole loaded folate-grafted solid lipid nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine. 2013 Jan 1; 9(1):111-21.
29. Shi LL, Xie H, Lu J, Cao Y, Liu JY, Zhang XX, Zhang H, Cui JH, Cao QR. Positively charged surface-modified solid lipid nanoparticles promote the intestinal transport of docetaxel through multifunctional mechanisms in rats. Molecular pharmaceutics. 2016 Aug 1; 13(8):2667-76.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).